G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 113 filers reported holding G1 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $6,319 | -89.9% | 2,358 | -79.6% | 0.00% | – |
Q4 2022 | $62,831 | -58.1% | 11,571 | -41.7% | 0.00% | – |
Q1 2022 | $150,000 | -25.4% | 19,837 | +0.6% | 0.00% | – |
Q4 2021 | $201,000 | +39.6% | 19,727 | +83.7% | 0.00% | – |
Q3 2021 | $144,000 | +32.1% | 10,741 | +117.6% | 0.00% | – |
Q2 2021 | $109,000 | -9.9% | 4,936 | -2.0% | 0.00% | – |
Q1 2021 | $121,000 | +45.8% | 5,036 | +10.0% | 0.00% | – |
Q4 2020 | $83,000 | +50.9% | 4,580 | -3.8% | 0.00% | – |
Q3 2020 | $55,000 | -63.1% | 4,761 | -22.8% | 0.00% | – |
Q2 2020 | $149,000 | +119.1% | 6,168 | +0.6% | 0.00% | – |
Q1 2020 | $68,000 | -66.5% | 6,130 | -20.2% | 0.00% | – |
Q4 2019 | $203,000 | +29.3% | 7,679 | +11.9% | 0.00% | – |
Q3 2019 | $157,000 | -16.9% | 6,861 | +11.2% | 0.00% | – |
Q2 2019 | $189,000 | +177.9% | 6,172 | +52.0% | 0.00% | – |
Q1 2019 | $68,000 | -12.8% | 4,060 | 0.0% | 0.00% | – |
Q4 2018 | $78,000 | -55.9% | 4,060 | +20.0% | 0.00% | – |
Q3 2018 | $177,000 | +25.5% | 3,384 | +4.1% | 0.00% | – |
Q2 2018 | $141,000 | +60.2% | 3,251 | +36.1% | 0.00% | – |
Q1 2018 | $88,000 | +151.4% | 2,388 | +35.7% | 0.00% | – |
Q4 2017 | $35,000 | +9.4% | 1,760 | +34.9% | 0.00% | – |
Q3 2017 | $32,000 | +966.7% | 1,305 | +695.7% | 0.00% | – |
Q2 2017 | $3,000 | – | 164 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |